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Abstract
Background: The U-shaped associations between sleep durations and cardiometabolic risk factors (glycated hemoglobin
levels, obesity, hypertriglyceridemia, hypertension and cholesterol levels) are still inconclusive. Moreover, as sleep is comprised
of quantitative and qualitative aspects, exploring both insomnia symptoms and sleep duration are relevant when evaluating
the potential effects of sleep problems on health. The aim was to evaluate sex-specific associations between sleep problems
and cardiometabolic risk factors.
Methods: This cross-sectional study used data from wave two of the Brazilian Longitudinal Study of Adult
Health (ELSA-Brasil), including 7491 women and 6232 men. Questionnaires were administered to provide
information about socioeconomic conditions, lifestyle, and sleep characteristics. A 12-h fasting blood sample
was drawn to measure serum cholesterol, triglycerides, and glycated hemoglobin. Blood pressure, weight and
height were also measured using standard equipment. Generalized additive models were used to evaluate the
curve shape of the relationship between self-reported sleep duration and the outcomes. Logistic regression
was performed to investigate the magnitude of the associations of self-reported sleep duration, insomnia
symptoms, and short sleep plus insomnia symptoms with cardiometabolic risk factors.
Results: For women, self-reported sleep duration and insomnia symptoms (either separately or linked to short
sleep duration) were associated with obesity, hypertension and glycated hemoglobin after adjusting for the
confounders. The magnitudes of the associations between self-reported short sleep duration plus insomnia
symptoms and the outcomes were slightly increased, considering sleep duration or insomnia symptoms
separately. For men, both long sleep duration and insomnia symptoms were associated with
hypertriglyceridemia after adjusted for the confounders.
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Conclusion: These findings suggest possible sex-specific patterns, since obesity, hypertension and high glycated
hemoglobin were associated with self-reported sleep duration and insomnia symptoms in women, but not in men,
and reinforce the importance of considering quantitative and qualitative aspects of sleep for the prevention and
management of the outcomes.
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Background
Studies into sleep have increased in recent decades, since
it was recognized as a public health issue due to the pos-
sible negative effects of sleep problems on health. Previous
studies have suggested a link between sleep duration and
diabetes, obesity, hypertension and metabolic syndrome
[1–9]. Findings related to sleep duration and plasma lipids
are scarce and less consistent [10–12], Although some
studies have found that both short and long sleep dura-
tions are associated with diabetes [5, 7, 11, 12], hyperten-
sion and obesity [11, 12], other studies did not observe
this U-shaped relationship [3, 12–16]. Moreover, the sleep
duration range that corresponds to the lowest risk of car-
diometabolic diseases remains unclear. In fact, the wide
variation in the reference category (i.e, adequate sleep)
across studies (from > 6 h to < 9 h) [3, 5, 6, 17] clearly
shows that the definition of the reference category de-
serves attention.
Concerning insomnia symptoms (difficulty initiating
sleep, difficulty maintaining sleep, early morning awak-
ening), the studies related to cardiometabolic issues are
less extensive [3], compared to the ones related to sleep
duration. Having difficulty falling or staying asleep (‘all
of the time’ or ‘most of the time’) was associated with
type 2 diabetes in young female registered nurses [18],
and with both hypertension and dyslipidemia among
public sector employees [19]. Meta-analysis studies
showed that the risk of type 2 diabetes [7] and hyperten-
sion [3] were, respectively, 84 and 20% higher for sub-
jects who reported difficulties in maintaining their sleep
[3, 7]. In a meta-analysis including studies on insomnia
and obesity published in the past 10 years, the authors
stated that associations are weak, particularly for Euro-
pean samples [19]. These findings stress that there is no
single pattern of results and reinforce the need for stud-
ies with other population groups.
As sleep is comprised of quantitative and qualitative
aspects, exploring both insomnia symptoms and sleep
duration are relevant when evaluating the potential ef-
fects of sleep problems on health. In this context, the
interaction between short sleep duration and insomnia
symptoms, which leads to increased health risks has also
been discussed [20, 21]. Cai et al. [22] found a significant
association between insomnia symptoms and obesity
among participants with short sleep duration, but not
among those who reported normal sleep duration (6–8
h). Similarly, short sleep duration with insomnia symp-
toms was associated with hypertension [23]. In relation
to diabetes, an association was observed in those with
chronic insomnia plus short sleep duration, but not
among those with insomnia symptoms plus short sleep
duration [24].
The above-mentioned associations do not specifically
comment on the possible different effects between men
and women, despite the known gender and sex differences
in relation to sleep problems [25–27]. Few studies have in-
vestigated sex-specific associations between sleep and
negative outcomes related to non-communicable chronic
diseases [5]. Gender differences have been detected in
studies of sleep problems, with significant associations in
women (but not men) with regard to hypertension [28],
the prevalence of dyslipidemia [29], and obesity [30]. Short
sleep duration was associated with a greater BMI and
waist circumference among women but not among men
[31]. However, as pointed out by Theorell-Haglöw et al.
[32] research on gender differences in sleep medicine ap-
pears to be limited. In a meta-analysis study on sleep and
type 2 diabetes, Shan et al. [5] emphasize the relevance of
data on sex, which were usually limited in the original
studies. These data reinforce the need for testing the hy-
pothesis of sex-differences in the association between
sleep patterns and cardiometabolic factors.
The mechanisms involved in the relationships between
sleep problems and metabolic disorders include reduced
glucose tolerance and compromised insulin sensitivity
[1]. Insulin and glucose alterations associated with sleep
restriction may be partially mediated by neuroendocrine
changes, including high evening cortisol levels and in-
creased sympathetic nervous system activity and cat-
echolamine production [33]. Nocturnal sleep deprivation
can lead to abnormal cortisol release during the night,
which may result in decreased sensitivity to insulin in
the morning. Elevations in cortisol and increased sympa-
thetic nervous system activity are also related to im-
paired vasodilatation and hypertension. Short sleep
duration also reduces heart rate variability [33], which
highlights the importance of sleep in the regulation of
many cardiometabolic functions [1].
Given all the gaps related to the associations of sleep
duration and insomnia symptoms with cardiometabolic
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diseases, and considering that hypertension, obesity,
hyperglycemia and dyslipidemia can lead to cardiovascu-
lar disease, the leading non-communicable diseases in
terms of premature deaths [34], this investigation may
provide relevant evidence concerning public health pri-
orities. Therefore the objective of this study was to in-
vestigate whether there are sex-specific patterns in the
association of cardiometabolic risk factors with (i) self-
reported short sleep duration, (ii) self-reported long
sleep duration, (iii) insomnia symptoms, and (iv) the
combination of insomnia symptoms and self-reported
short sleep duration.
Methods
Study population and setting of the study
This cross-sectional study used data from wave two
(2012–2014) of the Brazilian Longitudinal Study of
Adult Health (ELSA-Brasil) [35], which was a multicen-
ter study following civil servants aged 35 to 74 yrs. old
who were recruited between August 2008 and December
2010 (first wave) at public institutions in six Brazilian
state capitals (Salvador, Belo Horizonte, Rio de Janeiro,
São Paulo, Vitória and Porto Alegre). The second wave
re-examined and interviewed 14,014 individuals. Wave 2
included data on sleep patterns (not evaluated in wave
1), which allowed us to perform the current analyses, in-
cluding 13,722 participants (7491 women and 6231
men) with complete data for all variables. A total of 292
participants with missing data on variables related to
self-reported sleep duration (n = 98), insomnia symp-
toms (n = 97) and outcomes (n = 42) was excluded. Par-
ticipants who reported sleep durations < 3 h or > 12 h
were also not considered in the analyses (n = 29 women
and 26 men).
Variables definition
A comprehensive set of questionnaires was administered
to provide detailed information on socioeconomic condi-
tions, habits, lifestyle, and health. The study design, sam-
pling procedures, construction of the questionnaire and
quality assurance and control measures were previously
detailed [36, 37].
Sleep variables
Self-reported sleep duration The self-report question-
naire included the question “How many hours of sleep do
you get in a usual night’s sleep? |__|__| hours |__|__|mi-
nutes” [14, 21, 28] Participants were classified into three
groups according to the exact sleep duration they re-
ported: the short sleep duration group (≤ 6 h), adequate
sleep duration group (> 6 h and ≤ 8 h) and long sleep dur-
ation (> 8 h).
Insomnia symptoms The following questions were
asked: “In relation to your sleep during the night, at home,
during the last 4 weeks, how often did you have difficulty
in falling asleep?”, “... wake up and have difficulty going to
sleep again?”, and “... wake up before the desired time and
not manage to sleep again?“ [21, 25] Participants who an-
swered never, rarely or sometimes were classified as no
complaint. Participants who answered almost always or al-
ways were classified as having a complaint. Participants
who reported any of the three described complaints were
assigned to the insomnia group.
Self-reported short sleep duration plus insomnia symp-
toms: this variable considered the combination of self-
reported sleep duration and insomnia symptoms. We
could not create a “long sleep duration + insomnia” cat-
egory because few participants (18 men and 45 women)
were classified in this group. Therefore, participants with
short self-reported sleep duration and insomnia symptoms
were compared with participants with adequate sleep du-
rations and without insomnia symptoms.
The test-retest reliability of insomnia symptoms and
self-reported sleep duration questions was assessed in a
subsample of 205 participants randomly recruited. Con-
sidering an interval of 7 to 14 days between the inter-
views, the reliability was evaluated using Kappa statistics
and intraclass correlation coefficient (ICC) with their re-
spective 95% confidence intervals (CI). The ICC for sleep
duration was good (ICC 0.761; 95% CI 0.685 to 0.819).
There was a substantial agreement for insomnia, and
Kappa values were 0.759 (95% CI 0.651 to 0.867).
Cardiometabolic variables
A 12-h fasting blood sample was drawn by venipuncture
in the morning (between 7:00 a.m. and 10:00 a.m.) soon
after each subject’s arrival at the clinic to measure serum
cholesterol, triglycerides, and glycated hemoglobin [35–
37]. Participants with glycated hemoglobin levels ≥6.5%
were classified in the high glycated hemoglobin group
[35]. Hypertriglyceridemia was defined as triglycerides
levels ≥150 mg/dL (milligrams per deciliter). HDL level <
40 mg/dL for men and < 50mg/dL for women defined
the low HDL group [35]. Hypertension was defined as a
systolic blood pressure ≥ 140 mmHg or, a diastolic blood
pressure ≥ 90 mmHg, or the use of medication to treat
hypertension [35]. Weight and height were also collected
using standard equipment and techniques. Obesity was
defined as body mass index (BMI) ≥ 30 kg/m2 [35].
Sociodemographic and health variables
The questionnaire also provided information on age, sex,
education (fundamental, high school or college), meno-
pausal status and leisure physical activity [PA]; this vari-
able was created considering questions related to the
frequency, duration and intensity of PA, categorized as
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follows: 1) none - no PA or some PA but not meeting
the other two categories; 2) moderate - ≥3 days of
vigorous-intensity PA for at least 20 min/day or ≥ 5 days
of moderate-intensity PA and/or walking, in combin-
ation or alone, at least 30 min/day or ≥ 5 days of any
combination of walking and moderate-or-vigorous-in-
tensity PA achieving a minimum of 600 MET [Metabolic
Equivalents]-minutes/week; and 3) high - vigorous-
intensity PA on at least 3 days, accumulating a minimum
of 1500 MET-minutes/week or ≥ 7 days of any combin-
ation of walking and moderate-or-vigorous intensity PA,
obtained using the International Physical Activity Ques-
tionnaire, (IPAQ long version) [38]. Depression symp-
toms ascertained using the Clinical Interview Schedule –
Revised (CIS– R) [39].
Statistical analyses
Descriptive analyses were performed to characterize
the participants by sex. Given the heterogeneity in
creating the range of reference categories for sleep
duration, firstly Generalized Additive Models with
Bernoulli distribution were used to evaluate the curve
shape for the relationship between self-reported sleep
duration and the outcomes and to determine the cut-
off for hours of sleep duration. The models were fit-
ted considering the potential confounders. After de-
termining the cut-offs for self-reported sleep duration
(≤ 6 h; > 6 h - ≤ 8 h; > 8 h), logistic regression analyses
were performed to investigate the magnitude of the
associations between self-reported sleep duration, in-
somnia symptoms and the cardiometabolic risk factors
(binary outcomes - high glycated hemoglobin levels,
obesity, hypertriglyceridemia, hypertension and low
HDL levels). The analyses were adjusted for potential
confounders. Model 1 tested a crude association.
Then, the analyses were adjusted for age and educa-
tion (model 2) and included physical activity and de-
pression symptoms (model 3). The fourth model was
adjusted for self-reported sleep duration or insomnia
symptoms to investigate independent effects. The last
model included menopausal status. Joint associations
of insomnia symptoms and self-reported sleep dur-
ation with all outcomes were examined considering
participants with adequate sleep duration (> 6 h - ≤ 8
h) and absence of insomnia symptoms as the refer-
ence group.
All analyses were performed using the software R ver-
sion 2.15.
Results
Participants in the ELSA-Brasil included 7491 women
and 6231 men in this study. For women and men, the
mean age was 55.6 years and 55 years. In relation to
sleep patterns, 47.6 and 49.1% of women and men,
respectively, reported short sleep duration; 4.5 and 3.2%,
respectively, reported long sleep duration; and 27.8 and
19.3% of women and men, respectively, reported insom-
nia symptoms. For both women and men, a higher pro-
portion of individuals with self-reported adequate sleep
durations was observed among those with a high level of
education, high level of physical activity, and obesity and
those without depressive symptoms. The group with in-
somnia symptoms was more likely to include partici-
pants with a low level of education, with no physical
activity and with depressive symptoms (Table 1).
For women, a U-shaped relationship was suggested
between self-reported sleep duration and obesity,
hypertension and glycated hemoglobin after adjusting
for the confounders; adequate self-reported sleep dur-
ation (> 6 h - ≤ 8 h) was not associated with cardio-
metabolic risk factors. In contrast, no significant
association between self-reported sleep duration and
the outcomes was observed for men, except for
hypertriglyceridemia, which seems to be related
mainly to long sleep duration (Fig. 1).
For women, in age-adjusted analyses revealed that self-
reported sleep duration and insomnia symptoms were
significantly associated with obesity, hypertension, low
HDL, and high glycated hemoglobin levels compared to
the respective reference groups. After adjusting for all
potential confounders, the associations remained statisti-
cally significant for obesity, hypertension, and high gly-
cated hemoglobin level, and the latter showed the
strongest association. Also in women, it should be noted
that for obesity, hypertension and high glycated
hemoglobin levels, the magnitudes of the associations
with the combination of self-reported short sleep dur-
ation with insomnia symptoms were higher than those
observed for the factors analyzed separately (Table 2).
As previously highlighted in Fig. 1, these associations
were not statistically significant for men, except for
hypertriglyceridemia; both long sleep duration and in-
somnia symptoms were associated with hypertriglyc-
eridemia after adjusted for the confounders (Table 3).
Discussion
Results suggest sex-specific patterns, since obesity,
hypertension and high glycated hemoglobin were associ-
ated with self-reported sleep duration and insomnia
symptoms (either separately or linked to short sleep dur-
ation) in women, but not in men. In addition, cardio-
metabolic risk factors were associated with insomnia
symptoms plus short sleep duration only in women. In
relation to hypertriglyceridemia, statistically significant
associations with insomnia symptoms were observed
among both women and men.
Observational studies have shown that the prevalence
of insomnia symptoms varies from 10 to 30% [3, 21, 25],
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and similar to our findings, insomnia symptoms are
more frequent among women than men [17, 25, 30].
This difference is more evident in self-reported data
than objective measures [26]. Regarding sleep duration,
our findings indicated that almost half of the sample re-
ported short sleep duration. This prevalence was higher
than those observed in other countries [11, 21, 31].
However, for long sleep duration, our findings are in
agreement with previous studies [31, 22].
Sex-specific patterns considering short sleep duration
Some studies reported significant associations between
sleep problems and cardiometabolic outcomes for
women but not men. Similar to our findings, in the
Whitehall cohort, short sleep duration was associated
with a higher risk of hypertension only in women [28].
Also, Grandner et al. [40] evaluated the association be-
tween hypertension and sleep duration in a large survey
population and observed that short sleep was more
closely related to hypertension in women than men. A
meta-analysis of the association between sleep duration
and hypertension revealed that the results from cross-
sectional studies suggested statistically significant associ-
ations between short sleep duration and hypertension in
women but not in men [8].
In relation to body weight, Westerlund et al. [30] ob-
served higher BMI values in women and men with short
sleep duration compared with adequate sleep duration
(6–8 h). On the other hand, similar to our findings, short
sleep duration was associated with a greater BMI among
women but not among men [31]. A recent meta-analysis
[6] showed an association between short sleep duration
Table 1 Sleep duration and insomnia symptoms according to sociodemographic and cardiometabolic risk factors by sex. Brazilian
Longitudinal Study of Adult Health (ELSA-Brasil, 2012–2014)
Women (N = 7491) Men (N = 6231)
Self-reported Sleep Duration Insomnia Symptoms Self-reported Sleep Duration Insomnia Symptoms
≤ 6 h
(n = 3564)
















Age (year)* 55.7 (8.8) 55.4 (8.6) 57.8 (9.6) 55.6 (8.7) 56.1 (8.8) 55.5 (8.9) 55.8 (9.5) 56.6 (9.4) 55.6 (9.2) 56.3 (9.2)
Education n(%)
Fundamental 332 (9.3) 237 (6.6) 50 (14.9) 358 (6.6) 261 (12.5) 473 (15.4) 385 (13.0) 50 (24.9) 657 (13.1) 251 (20.9)
High school 1235 (34.6) 1041 (29.0) 134 (40.0) 1675 (31.0) 735 (35.3) 967 (31.6) 859 (28.9) 78 (38.9) 1509 (30.0) 395 (32.9)
College 1997 (56.1) 2314 (64.4) 151 (45.1) 3373 (62.4) 1089 (52.2) 1623 (53.0) 1724 (58.1) 72 (36.2) 2865 (56.9) 554 (46.2)
Physical activity n(%)
No 2848 (79.9) 2694 (75.0) 278 (83.0) 4116 (76.1) 1704 (81.7) 2199 (71.8) 2008 (67.6) 150 (75.1) 3481 (69.2) 876 (73.0)
Moderate 514 (14.2) 675 (18.8) 44 (13.1) 946 (17.5) 287 (13.8) 541(17.7) 632 (21.3) 28 (13.9) 984 (19.6) 217 (18.1)
High 202 (5.7) 223 (6.2) 13 (3.9) 344 (6.4) 94 (4.5) 323 (10.5) 328 (11.1) 22 (11.0) 566 (11.2) 107 (8.9)
BMI n(%)
Non obese 2436 (68.4) 2677 (74.5) 208 (62.1) 3927 (72.6) 1394 (66.9) 2343 (76.5) 2293 (77.3) 146 (73.0) 3863 (76.8) 919 (76.6)
Obese 1128 (31.6) 915 (25.5) 127 (37.9) 1479 (27.6) 691 (33.1) 720 (23.5) 675 (22.7) 54 (27.0) 1168 (23.2) 281 (23.4)
Low HDL n(%)
No 2556 (71.7) 2694 (75.0) 233 (69.6) 4017 (74.3) 1466 (70.3) 2388 (77.9) 2324 (78.3) 157 (78.5) 3928 (78.1) 941 (78.4)
Yes 1008 (28.3) 898 (25.0) 102 (30.4) 1389 (25.7) 619 (29.7) 675 (22.1) 644 (21.7) 43 (21.5) 1103 (21.9) 259 (21.6)
Hypertriglyceridemia n(%)
No 2787 (78.2) 2868 (79.8) 254 (75.8) 4325 (80.0) 1584 (76.0) 1996 (65.2) 1922 (64.8) 105 (52.5) 3278 (65.2) 745 (62.1)
Yes 777 (21.8) 724 (20.2) 81 (24.2) 1081 (20.0) 501 (24.0) 1067 (34.8) 1046 (35.2) 95 (47.5) 1753 (34.8) 455 (37.9)
High glycated hemoglobin n(%)
No 3278 (91.9) 3375 (93.9) 294 (87.8) 5066 (93.7) 1881 (90.2) 2765 (90.3) 2676 (90.2) 180 (89.9) 4559 (90.6) 1062 (88.5)
Yes 286 (8.1) 217 (6.1) 41 (12.2) 340 (6.3) 204 (9.8) 298 (9.7) 292 (9.8) 20 (10.1) 472 (9.4) 138 (11.5)
Hypertension n(%)
No 2151 (60.3) 2381 (66.3) 169 (50.4) 3513 (65.0) 1188 (57.0) 1682 (54.9) 1652 (55.7) 102 (51.1) 2814 (55.9) 622 (51.8)
Yes 1413 (39.7) 1211 (33.7) 166 (49.6) 1893 (35.0) 897 (43.0) 1381 (45.1) 1316 (44.3) 98 (48.9) 2217 (44.1) 578 (48.2)
Depressive symptoms n(%)
No 2782 (78.1) 3101 (86.3) 283 (84.5) 4800 (88.8) 1366 (65.5) 2714 (88.6) 2757 (92.9) 180 (90.0) 4702 (93.5) 949 (79.1)
Yes 782 (21.9) 491(13.7) 52 (15.5) 606 (11.2) 719 (34.5) 211 (11.4) 349 (7.1) 20 (10.0) 329 (6.5) 251 (20.9)
* mean (standard deviation)
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and the risk for obesity (lowest risk at 7–8 h sleep/day),
stressing that the associations seem to be more evident
in women than men. However, conclusions were not yet
possible given the few studies addressing possible gender
differences [6]. The same limitation was pointed out by
Shan et al. [5], who found an association between short
sleep duration and an increased risk for type 2 diabetes
in a meta-analysis of prospective studies with adult
populations. In contrast, our findings on the association
between short sleep duration and high glycated
hemoglobin were not statistically significant in women
or men, although a greater tendency for a positive asso-
ciation was observed among women. Regarding plasma
lipids, similar to our results, Kim et al. [41] did not iden-
tify associations between short sleep duration and dyslip-
idemia in women or men. However, meta-analyses
Fig. 1 Cardiometabolic risk factors by self-reported sleep duration. ELSA-Brasil (2012–2014). Generalized Additive Models (adjusted for all potential
confounders) were used to evaluate the curve shape for the relationship between self-reported sleep duration and the outcomes. The solid black
line represents the regression line and the dotted lines represent the 95% confidence interval. The horizontal red line indicates that there is
no association
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Table 2 Association (odds ratio [95%CI]) between sleep patterns and cardiometabolic risk factors among women. Brazilian
Longitudinal Study of Adult Health (ELSA-Brasil, 2012–2014)
Obesity
Model 1 Model 2 Model 3 Model 4 Model 5
Self-reported sleep duration
≤ 6 h 1.35 (1.22;1.50) 1.29 (1.16;1.43) 1.25 (1.13;1.39) 1.23 (1.10;1.37) 1.22 (1.09;1.36)
> 6 - ≤ 8 h Reference category
> 8 h 1.79 (1.41;2.25) 1.59 (1.25;2.01) 1.55 (1.22;1.97) 1.56 (1.23;1.97) 1.56 (1.23;1.98)
Insomnia symptoms
No Reference category
Yes 1.32 (1.18;1.47 1.23 (1.10;1.38) 1.15 (1.02;1.29) 1.09 (0.97;1.23) 1.09 (0.96;1.23)
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.58 (1.38;1.81) 1.43 (1.25;1.65) 1.32 (1.14;1.53) – 1.31 (1.13;1.51)
Hypertension
Self-reported sleep duration
≤ 6 h 1.29 (1.17;1.42) 1.29 (1.17;1.43) 1.19 (1.08;1.33) 1.15 (1.03;1.28) 1,15 (1.03;1.28)
> 6 - ≤ 8 h Reference category
> 8 h 1.93 (1.54;2.42) 1.73 (1.36;2.19) 1.52 (1.19;1.93) 1.53 (1.20;1.94) 1.53 (1.20;1.95)
Insomnia symptoms
No Reference category
Yes 1.40 (1.26;1.55) 1.39 (1.24;1.54) 1.22 (1.09;1.37) 1.19 (1.05;1.33) 1.18 (1.05;1.33)
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.62 (1.43;1.84) 1.46 (1.28;1.67) 1.37 (1.19;1.58) – 1.33 (1.15;1.53)
High glycated hemoglobin
Self-reported sleep duration
≤ 6 h 1.36 (1.13;1.63) 1.35 (1.12;1.62) 1.20 (1.00;1.45) 1.12 (0.92;1.36) 1.11 (0.91;1.36)
> 6 - ≤ 8 h Reference category
> 8 h 2.17 (1.50;3.06) 1.90 (1.31;2.70) 1.62 (1.11;2.32) 1.64 (1.13;2.34) 1.65 (1.13;2.23)
Insomnia symptoms
No Reference category
Yes 1.62 (1.35;1.94) 1.59 (1.31;1.89) 1.32 (1.09;1.60) 1.31 (1.06;1.61) 1.30 (1.06;1.60)
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.91 (1.52;2.39) 1.60 (1.27;2.01) 1.48 (1.17;1.88) – 1.43 (1.12;1.82)
Hypertriglyceridemia
Self-reported sleep duration
≤ 6 h 1.10 (0.99;1.24) 1.10 (0.98;1.23) 1.05 (0.93;1.17) 1.04 (0.89;1.13) 0.99 (0.88;1.12)
> 6 - ≤ 8 h Reference category
> 8 h 1.26 (0.96;1.64) 1.20 (0.91;1.55) 1.11 (0.84;1.44) 1.11 (0.85;1.44) 1.12 (0.86;1.46)
Insomnia symptoms
No Reference category
Yes 1.27 (1.12;1.43) 1.25 (1.11;1.41) 1.17 (1.03;1.33) 1.17 (1.03;1.34) 1.16 (1.01;1.32)
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highlight the lack of sufficient evidence to support any
conclusion on this issue [10, 29].
Sex-specific patterns considering long sleep duration
Westerlund et al. [30] also observed higher BMI values in
women with long sleep duration. In contrast, long sleep
duration was associated with lower BMI values in men.
Kim et al. [41] observed significant associations of long
sleep duration with central obesity, low HDL, and high
fasting glucose levels among women but not among men.
According to our data, long sleep duration was associated
with elevated triglyceride levels only among men [41],
which deserves further investigations. As mentioned
above, recent meta-analyses have addressed the associ-
ation between sleep duration and cardiometabolic risk fac-
tors, but sex-differences approaches are scarce. A reverse
J-shaped relationship was described in a recent meta-
analysis, with a borderline association between long sleep
duration and the risk of obesity [6]. A meta-analysis of
longitudinal studies that examined the association be-
tween sleep duration and diabetes showed that long sleep
duration were associated with a significantly increased risk
of diabetes compared with 7–8 h of sleep/day [5].
Concerning the U-shaped relationship between sleep
duration and hypertension, a meta-analysis found that the
results from prospective studies showed that neither short
nor long sleep duration was statistically associated with
the risk of incident hypertension [8]. However, similar to
our findings for women, analyses from cross-sectional
studies showed that both short and long sleep durations
were associated with prevalent hypertension in adults [8].
Another meta-analysis of cohort studies showed signifi-
cant associations between short sleep duration and higher
risk of hypertension [3]. However, the authors found no
statistical evidence of any effect of long sleep duration on
the risk of hypertension [3]. A meta-analysis of prospect-
ive studies identified that short sleep duration was signifi-
cantly associated with increased risk of obesity, whereas
long sleep duration had no effects on obesity [16]. A sys-
tematic review with meta-analyses examining the relation-
ship between short sleep duration and several health
outcomes identified significant results for diabetes, hyper-
tension, cardiovascular disease and obesity [11]. The re-
sults from this same research group showed that long
sleep duration was significantly associated with diabetes
and obesity, but not with increased risk of hypertension
[12]. In summary, the literature is not entirely consistent
with respect to the U-shaped associations between sleep
duration and metabolic outcomes. Some results from
meta-analyses including longitudinal studies have showed
statistically significant associations of both short and long
sleep duration with diabetes and obesity [5, 12], while
other studies that evaluated hypertension and obesity did
not identify any associations [3, 16]. Part of these disagree-
ments could be attributed to methodological issues, such
as the instrument used to assess sleep duration and the
outcomes (subjective or objective measure), the cut-offs
for sleep duration, and the duration of follow-up [3].
Sex-specific patterns considering insomnia symptoms
Sex-specific patterns concerning the association between
insomnia symptoms and cardiometabolic factors are
Table 2 Association (odds ratio [95%CI]) between sleep patterns and cardiometabolic risk factors among women. Brazilian
Longitudinal Study of Adult Health (ELSA-Brasil, 2012–2014) (Continued)
Obesity
Model 1 Model 2 Model 3 Model 4 Model 5
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.31 (1.13;1.52) 1.23 (1.06;1.43) 1.18 (1.01;1.38) – 1.12 (0.95;1.31)
Low HDL-cholesterol
Self-reported sleep duration
≤ 6 h 1.18 (1.06;1.31) 1.19 1.07;1.32) 1.13 (1.01;1.25) 1.10 (0.99;1.23) 1.10 (0.98;1.23)
> 6 - ≤ 8 h Reference category
> 8 h 1.31 (1.03;1.67) 1.36 (1.06;1.74) 1.24 (0.97;1.59) 1.25 (0.97;1.59) 1.25 (0.97;1.59)
Insomnia symptoms
No Reference category
Yes 1.22 (1.09;1.36) 1.23 (1.10;1.38) 1.13 (1.00;1.27) 1.10 (0.97;1.25) 1.10 (0.96;1.25)
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.33 (1.16;1.53) 1.27 (1.10;1.46) 1.21 (1.04;1.39) – 1.19 (1.03;1.38)
Logistic regression analyses (odds ratio and 95% CI). Model 1 = crude model; Model 2 = Model1 + age + education; Model 3 = Model 2 + physical activity +
depression; Model 4 = Model 3 + insomnia or sleep duration; Model 5 =Model 4 +menopausal status
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Table 3 Association (odds ratio [95%CI]) between sleep patterns and cardiometabolic risk factors among men. Brazilian Longitudinal
Study of Adult Health (ELSA-Brasil, 2012–2014)
Obesity
Model 1 Model 2 Model 3 Model 4
Self-reported sleep duration
≤ 6 h 1.04 (0.93;1.18) 1.03 (0.91;1.16) 1.02 (0.90;1.15) 1.02 (0.90;1.16)
> 6 - ≤ 8 h Reference category
> 8 h 1.26 (0.90;1.73) 1.22 (0.87;1.62) 1.20 (0.86;1.65) 1.06 (0.86;1.65)
Insomnia symptoms
No Reference category
Yes 1.01 (0.87;1.17) 1.00 (0.86;1.16) 0.99 (0.85;1.15) 0.99 (0.84;1.16)
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.07 (0.89;1.27) 1.04 (0.87;1.27) 1.02 (0.85;1.23) –
Hypertension
Self-reported sleep duration
≤ 6 h 1.03 (0.93;1.14) 1.04 (0.94;1.16) 1.03 (0.93;1.15) 1.02 (0.91;1.14)
> 6 - ≤ 8 h Reference category
> 8 h 1.19 (0.89;1.59) 1.06 (0.78;1.44) 1.06 (0.78;1.43) 1.06 (0.78;1.43)
Insomnia symptoms
No Reference category
Yes 1.18 (1.04;1.34) 1.09 (0.96;1.25) 1.07 (0.94;1.23) 1.07 (0.93;1.23)
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.21 (1.04;1.41) 1.13 (0.97;1.33) 1.11 (0.94–1.30) –
High glycated hemoglobin
Self-reported sleep duration
≤ 6 h 0.99 (0.83;1.17) 0.97 (0.82;1.15) 0.95 (0.79;1.12) 0.93 (0.78;1.11)
> 6 - ≤ 8 h Reference category
> 8 h 1.07 (0.65;1.67) 0.88 (0.53;1.39) 0.87 (0.53;1.37) 0.87 (0.53;1.37)
Insomnia symptoms
No Reference category
Yes 1.25 (1.02;1.53) 1.11 (0.90;1.36) 1.04 (0.84;1.28) 1.06 (0.85;1.32)
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.19 (0.93;1.51) 1.05 (0.82;1.34) 0.98 (0.75;1.25) –
Hypertriglyceridemia
Self-reported sleep duration
≤ 6 h 0.98 (0.88;1.09) 0.97 (0.87;1.08) 0.96 (0.86;1.07) 0.93 (0.84;1.04)
> 6 - ≤ 8 h Reference category
> 8 h 1.65 (1.24;2.19) 1.60 (1.20;2.14) 1.59 (1.19;2.13) 1.60 (1.20;2.14)
Insomnia symptoms
No Reference category
Yes 0.98 (0.84;1.14) 1.13 (0.99;1.29) 1.13 (0.99;1.29) 1.17 (1.02;1.35)
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scarce. Cross-sectional analyses [30] showed higher BMI
values in women with insomnia symptoms, and a similar
pattern but less marked among men. In contrast to our
findings, insomnia was associated with a hypertriglyc-
eridemia in women, but significant results were not
found in men [29]. Also, difficulty maintaining sleep was
associated with an increased overall risk for cardiovascu-
lar events in women, but not men [42].
Regarding data from the general population without
discussion of sex-specificities, insomnia symptoms were
associated with hypertension medication [43], dyslipid-
emia medication [43], and type 2 diabetes [7]. A meta-
analysis of cohort studies showed that insomnia symp-
toms were significantly associated with a higher risk of
hypertension [3]. However, among individuals with ad-
equate sleep duration, insomnia symptoms were not as-
sociated with obesity [22].
Joint associations of insomnia and short sleep duration
A recent study found a significant association between
insomnia symptoms and obesity among participants with
short sleep duration, but not among those who reported
adequate sleep duration [22]. In the same way, short
sleep duration with insomnia symptoms was associated
with hypertension [23] and diabetes [24]. In a cross-
sectional study, associations between sleep duration and
BMI were not modified by insomnia symptoms [30].
Our findings on the associations between self-reported
sleep duration and each outcome independent of insom-
nia symptoms (and vice versa) also deserve attention. It
has been discussed that insomnia and short sleep
duration are distinct aspects of sleep that exhibit inter-
sections. We did not find distinct results after adjusting
for insomnia or sleep duration, i.e., the magnitude of the
association was similar regardless of the adjustment for
the other sleep variable. However, the combination of
insomnia symptoms and self-reported short sleep dur-
ation appears to intensify the adverse effects of sleep
problems separately from the independent associations
[20, 21]. Therefore, in line with previous studies [23, 24],
we found that the magnitudes of the associations be-
tween self-reported short sleep duration plus insomnia
symptoms and the outcomes were slightly increased.
These findings stress the relevance of considering sleep
problems as an additional risk of disease.
Possible explanations and mechanisms
In line with our findings, Prather et al. [27] showed that
associations between sleep quality and biomarkers were
stronger in women than in men. Poorer sleep quality
was associated with 5-years increases in Interleukin 6,
C-reactive protein, and fibrinogen in women but not in
men. Therefore, causal pathways may be different for
men and women. Therefore, causal pathways may be dif-
ferent for men and women. A laboratory study examin-
ing the effects of sleep deprivation on neural
cardiovascular control in men and women found that
sleep deprivation decreased muscle sympathetic nerve
activity only in men, which in turn exerted a protective
function on blood pressure [44]. Concerning differences
in levels of reproductive hormones, it is possible that
testosterone, which is higher in men, may attenuate the
Table 3 Association (odds ratio [95%CI]) between sleep patterns and cardiometabolic risk factors among men. Brazilian Longitudinal
Study of Adult Health (ELSA-Brasil, 2012–2014) (Continued)
Obesity
Model 1 Model 2 Model 3 Model 4
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.14 (0.97;1.33) 1.12 (0.96;1.31) 1.11 (0.94;1.30) –
Low HDL-cholesterol
Self-reported sleep duration
≤ 6 h 1.02 (0.90;1.15) 1.01 (0.89;1.14) 0.99 (0.88;1.12) 1.01 (0.89;1.14)
> 6 - ≤ 8 h Reference category
> 8 h 0.98 (0.69;1.38) 0.95 (0.66;1.33) 0.93 (0.65;1.31) 0.93 (0.65;1.31)
Insomnia symptoms
No Reference category
Yes 0.98 (0.84;1.14) 0.96 (0.83;1.12) 0.93 (0.80;1.09) 0.93 (0.79;1.09)
Short sleep + insomnia
No (> 6 - ≤ 8 h and absence of insomnia) Reference category
Yes 1.01 (0.84;1.21) 0.98 (0.82;1.18) 0.94 (0.78;1.13) –
Logistic regression analyses (odds ratio and 95% CI). Model 1 = crude model; Model 2 = Model 1 + age + education; Model 3 = Model 2 + physical activity +
depression; Model 4 = Model 3 + insomnia or sleep duration
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effects of poor sleep on inflammation. Supporting this hy-
pothesis, lower circulating levels of estradiol contribute to
the increased levels of inflammatory activity associated
with poor sleep in women around the menopausal period
(~ 55 years) [27]. The association between sleep problems
and greater psychological distress in women but not in
men [26] could also explain these differences. Greater psy-
chological distress in women is generally attributed to a
more stressful role for women in Western societies.
Although sex-specific association between sleep and car-
diometabolic problems represents an important research
area [5, 6, 32], the mechanisms underlying the different
patterns are not completely elucidated because few studies
have investigated sex differences related to this issue [41].
Therefore, further studies on sex differences and more
mechanism studies are needed to clarify this issue.
In a general way, the biological evidence supporting a
putative mechanism between sleep deprivation and car-
diometabolic outcomes is derived from disturbances in
autonomic function, and inflammatory and hormonal
profiles [33]. For instance, sleep reduction affects energy
balance, increases energy intake and reduces energy ex-
penditure. Nocturnal awakening is also associated with
altered leptin levels that lead to leptin resistance and re-
sult in glucose impairment. Elevated appetite could lead
to weight gain and in turn, increases insulin resistance
[5, 32]. Possible pathways for the association between
long sleep duration and cardiometabolic disease are not
clear. Some authors discuss the possibility that long
sleepers are previously sick individuals, and for that rea-
son, these associations should be observed in this group.
Long sleep is also associated with others sleep disorders,
such as obstructive sleep apnea, and poor-quality sleep
(increased sleep fragmentation and more frequent awak-
enings), which lead to changes in inflammatory markers
that have been shown to be associated with metabolic dys-
regulation [17, 33, 45]. Disagreeing with the hypothesis
that morbidity leads to long sleep duration, some studies
stress the significant associations of long sleep duration
with mortality, diabetes and other diseases, after control-
ling for other comorbidities [17, 45, 46]. It should be noted
that in the study of the joint associations of insomnia and
sleep duration with diabetes, the adjustment for body mass
index did not attenuate associations of long sleep duration
without insomnia and diabetes [17]. In this way, a sensitiv-
ity analysis by exclusion of the participants diagnosed with
myocardial infarction, stroke, and cancer during the first
2 years of follow-up did not change the association be-
tween long sleep duration and diabetes [45]. Clearly, there
is a demand for further studies on long sleepers.
Strengths and weakness
The strengths of this study are the large multicenter
sample of middle-aged Brazilians, the use of standard
equipment and techniques and the rigorous quality con-
trol of interviews and all measurements. All outcomes
included were evaluated by objective measures. Also, we
investigated the relationship between sleep duration and
the cardiometabolic risk factors, examining firstly if the
shape of these possible associations was linear or nonlin-
ear in order to determine the cut off points for sleep
duration based on the patterns of our sample.
The limitations of this study include the fact that all
sleep variables were self-reported. Also, the insomnia
symptoms did not include information related to day-
time dysfunction. Although measuring objective sleep
duration is more accurate, this procedure is generally
not feasible in large epidemiological samples [5, 10]. The
current study demonstrated substantial reliability for in-
somnia symptoms and self-reported sleep duration ques-
tions. Also, objective sleep-duration measures seemed to
be more strongly associated with hypertension than self-
reported sleep duration, with no statistically significant
differences [3]. Second, we did not have enough infor-
mation to distinguish participants who were naturally
short sleepers (short sleep duration but feel rested) from
the others, and there may be differences between those
groups. However, the investigation of individuals who
reported short sleep duration plus insomnia symptoms
showed results in the same direction of those observed
for short sleepers. Therefore, we supposed that most in-
dividuals who reported short sleep duration do not have
high sleep quality. Third, although the cross-sectional
study design did not allow us to infer causality, the lit-
erature on sleep and metabolic disorders suggests that
sleep problems most likely enhance the probability of
developing cardiometabolic outcomes [24]. Fourth, our
plasma measures were obtained based on standard pro-
cedures between 7:00 a.m. and 10:00 a.m., but the exact
moment of assessment was not recorded. As we expect a
diurnal variation for some biological markers, the timing
of the blood test could be a potential confounder that
was not considered. Fifth, we recognize the relevance of
age in analysis of cardiometabolic factors. Nevertheless,
our sample size (only ~ 4% reported long sleep duration)
did not allow us to deeply study age effects – for in-
stances, only 41 individuals with high glycated
hemoglobin levels reported long sleep duration). Finally,
our study sample comprises a particular population
(Brazilian civil servants) and the generalization of our
findings should be done with caution.
Conclusions
Our findings contribute to the discussion on the import-
ance of adequate sleep quality and duration and may
have important clinical and public health implications,
mainly in relation to primary prevention. It is essential
to identify modifiable life factors associated with a lower
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risk for developing non-communicable diseases, as pro-
posed in the present study. Assessing the associations
between sleep problems and cardiometabolic outcomes
according to gender contributes to filling the gap in the
literature on possible gender differences, highlighted in
recent systematic reviews with meta-analyses. The inves-
tigation of the lipid profile deserves further attention,
since studies on this issue are still rare and inconclusive.
The study contributes to the recognition that sleeping >
6 h to ≤8 h per night can be treated as presenting the
lowest risk for cardiometabolic risk factors. Lastly, the
associations of self-reported short sleep duration plus in-
somnia symptoms with higher likelihoods of obesity,
hypertension and high glycated hemoglobin levels rein-
forces the importance of considering quantitative and
qualitative aspects of sleep for the prevention and man-
agement of the outcomes.
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